Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Superior Vena Cava Syndrome | 2 | 2025 | 14 | 0.910 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2025 | 14 | 0.880 |
Why?
|
| Benzodiazepines | 1 | 2025 | 107 | 0.870 |
Why?
|
| Hypnotics and Sedatives | 1 | 2025 | 132 | 0.830 |
Why?
|
| Stents | 3 | 2025 | 799 | 0.830 |
Why?
|
| Ureteral Obstruction | 1 | 2025 | 88 | 0.820 |
Why?
|
| Emergency Medicine | 1 | 2025 | 172 | 0.790 |
Why?
|
| Foreign-Body Migration | 1 | 2024 | 65 | 0.780 |
Why?
|
| Aneurysm, False | 1 | 2024 | 84 | 0.750 |
Why?
|
| Device Removal | 1 | 2024 | 225 | 0.710 |
Why?
|
| Embolization, Therapeutic | 1 | 2024 | 233 | 0.670 |
Why?
|
| Alcohol Drinking | 3 | 2018 | 341 | 0.600 |
Why?
|
| Mortality | 2 | 2018 | 264 | 0.520 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 887 | 0.460 |
Why?
|
| Lipoproteins | 1 | 2016 | 183 | 0.440 |
Why?
|
| Liver Transplantation | 1 | 2023 | 1147 | 0.420 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2025 | 86 | 0.410 |
Why?
|
| Fatty Acids | 1 | 2016 | 377 | 0.400 |
Why?
|
| Amino Acids | 1 | 2016 | 566 | 0.400 |
Why?
|
| Metabolome | 1 | 2016 | 326 | 0.400 |
Why?
|
| Treatment Outcome | 8 | 2025 | 12936 | 0.320 |
Why?
|
| Global Health | 1 | 2015 | 626 | 0.320 |
Why?
|
| Renal Dialysis | 2 | 2025 | 951 | 0.260 |
Why?
|
| Kidney Failure, Chronic | 2 | 2025 | 934 | 0.250 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2025 | 767 | 0.250 |
Why?
|
| Endovascular Procedures | 2 | 2025 | 802 | 0.250 |
Why?
|
| Prosthesis Design | 3 | 2025 | 643 | 0.250 |
Why?
|
| Midazolam | 1 | 2025 | 51 | 0.230 |
Why?
|
| Hepatic Artery | 1 | 2024 | 45 | 0.200 |
Why?
|
| Humans | 18 | 2025 | 131163 | 0.200 |
Why?
|
| Ureter | 1 | 2025 | 84 | 0.200 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 2121 | 0.190 |
Why?
|
| Absorbable Implants | 1 | 2023 | 24 | 0.190 |
Why?
|
| Everolimus | 1 | 2023 | 50 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2018 | 1717 | 0.190 |
Why?
|
| Pericardium | 1 | 2023 | 103 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2023 | 246 | 0.180 |
Why?
|
| Equipment Design | 1 | 2024 | 512 | 0.180 |
Why?
|
| Coronary Disease | 2 | 2016 | 624 | 0.180 |
Why?
|
| Steel | 1 | 2021 | 2 | 0.180 |
Why?
|
| Transportation of Patients | 1 | 2021 | 51 | 0.160 |
Why?
|
| Hemorrhage | 1 | 2024 | 487 | 0.160 |
Why?
|
| Risk Factors | 6 | 2025 | 11074 | 0.150 |
Why?
|
| Catheter Ablation | 1 | 2022 | 324 | 0.150 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 630 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 314 | 0.140 |
Why?
|
| Echocardiography | 1 | 2023 | 1125 | 0.130 |
Why?
|
| Stroke | 2 | 2016 | 1061 | 0.130 |
Why?
|
| Palliative Care | 1 | 2021 | 443 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1224 | 0.130 |
Why?
|
| Finland | 1 | 2016 | 46 | 0.120 |
Why?
|
| Body Height | 1 | 2016 | 192 | 0.120 |
Why?
|
| Overweight | 1 | 2018 | 387 | 0.110 |
Why?
|
| Critical Care | 1 | 2021 | 686 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2025 | 80 | 0.110 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 18 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 688 | 0.110 |
Why?
|
| Vascular Patency | 2 | 2025 | 185 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2021 | 1050 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 982 | 0.100 |
Why?
|
| Aged | 5 | 2025 | 21025 | 0.100 |
Why?
|
| Hypertension | 1 | 2022 | 1356 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 853 | 0.100 |
Why?
|
| Metabolomics | 1 | 2016 | 501 | 0.090 |
Why?
|
| Male | 8 | 2025 | 64957 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 1373 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3829 | 0.090 |
Why?
|
| Female | 8 | 2025 | 70963 | 0.090 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2025 | 492 | 0.080 |
Why?
|
| Biomarkers | 2 | 2016 | 3385 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17753 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2833 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2015 | 722 | 0.070 |
Why?
|
| Adult | 5 | 2025 | 31282 | 0.060 |
Why?
|
| Survival Rate | 2 | 2025 | 2114 | 0.060 |
Why?
|
| Obesity | 1 | 2018 | 2426 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 6797 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2016 | 100 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2025 | 221 | 0.050 |
Why?
|
| Microwaves | 1 | 2022 | 8 | 0.050 |
Why?
|
| Middle Aged | 5 | 2025 | 28601 | 0.050 |
Why?
|
| Albuminuria | 1 | 2022 | 107 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 39 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2021 | 66 | 0.040 |
Why?
|
| Esophagus | 1 | 2022 | 258 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2021 | 109 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 414 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 566 | 0.040 |
Why?
|
| United Kingdom | 1 | 2018 | 267 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1216 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 6459 | 0.030 |
Why?
|
| Critical Illness | 1 | 2021 | 630 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2016 | 106 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 506 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 222 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2701 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6196 | 0.030 |
Why?
|
| Triglycerides | 1 | 2016 | 602 | 0.030 |
Why?
|
| Cholesterol | 1 | 2016 | 539 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 587 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1797 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 483 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1345 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 5196 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4886 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2595 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3436 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 10103 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20987 | 0.010 |
Why?
|